Kowa Pharmaceuticals America announced the U.S. Court of Appeals for the Federal Circuit has affirmed the decision by the U.S. District Court for the Southern District of New York, upholding the validity of U.S. Patent No. 8,557,993....
Under the terms of the agreement, Kowa and Nissan grant Zydus a licence to market Zydus’ generic version of Livalo beginning on May 2, 2023, or earlier under certain circumstances